These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37550251)

  • 1. Absorption matters: A closer look at popular oral bioavailability rules for drug approvals.
    Caminero Gomes Soares A; Marques Sousa GH; Calil RL; Goulart Trossini GH
    Mol Inform; 2023 Nov; 42(11):e202300115. PubMed ID: 37550251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.
    O' Donovan DH; De Fusco C; Kuhnke L; Reichel A
    J Med Chem; 2023 Feb; 66(4):2347-2360. PubMed ID: 36752336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating physiochemical properties of FDA-approved orally administered drugs.
    Reese TC; Devineni A; Smith T; Lalami I; Ahn JM; Raj GV
    Expert Opin Drug Discov; 2024 Feb; 19(2):225-238. PubMed ID: 37921049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Drug-likeness Rules Apply to Oral Prodrugs?
    Protti ÍF; Rodrigues DR; Fonseca SK; Alves RJ; de Oliveira RB; Maltarollo VG
    ChemMedChem; 2021 May; 16(9):1446-1456. PubMed ID: 33471444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five.
    Chen X; Li H; Tian L; Li Q; Luo J; Zhang Y
    J Comput Biol; 2020 Sep; 27(9):1397-1406. PubMed ID: 32031890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rule of five violations among the FDA-approved small molecule protein kinase inhibitors.
    Roskoski R
    Pharmacol Res; 2023 May; 191():106774. PubMed ID: 37075870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular properties that influence the oral bioavailability of drug candidates.
    Veber DF; Johnson SR; Cheng HY; Smith BR; Ward KW; Kopple KD
    J Med Chem; 2002 Jun; 45(12):2615-23. PubMed ID: 12036371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
    Möbitz H
    ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Lipophilicity and ADME Properties of 1,9-Diazaphenothiazines with Anticancer Action.
    Morak-Młodawska B; Jeleń M; Martula E; Korlacki R
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Brazilian compound library (BraCoLi) database: a repository of chemical and biological information for drug design.
    Veríssimo GC; Dos Santos Júnior VS; de Almeida IADR; Ruas MSM; Coutinho LG; de Oliveira RB; Alves RJ; Maltarollo VG
    Mol Divers; 2022 Dec; 26(6):3387-3397. PubMed ID: 35089481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of natural products upon modern drug discovery.
    Ganesan A
    Curr Opin Chem Biol; 2008 Jun; 12(3):306-17. PubMed ID: 18423384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models.
    Colodette NM; Franco LS; Maia RC; Fokoue HH; Sant'Anna CMR; Barreiro EJ
    J Comput Aided Mol Des; 2020 Oct; 34(10):1091-1103. PubMed ID: 32601839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability.
    Damião MC; Pasqualoto KF; Polli MC; Parise Filho R
    J Pharm Pharm Sci; 2014; 17(4):532-40. PubMed ID: 25579432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs.
    Bhanot A; Sundriyal S
    ACS Omega; 2021 Mar; 6(9):6424-6437. PubMed ID: 33718733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of specific "drug-like property" rules for carboxylate-containing oral drug candidates.
    Böcker A; Bonneau PR; Hucke O; Jakalian A; Edwards PJ
    ChemMedChem; 2010 Dec; 5(12):2102-13. PubMed ID: 20979082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going further than Lipinski's rule in drug design.
    Walters WP
    Expert Opin Drug Discov; 2012 Feb; 7(2):99-107. PubMed ID: 22468912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive computational target fishing approach to identify Xanthorrhizol putative targets.
    Shahid M; Azfaralariff A; Law D; Najm AA; Sanusi SA; Lim SJ; Cheah YH; Fazry S
    Sci Rep; 2021 Jan; 11(1):1594. PubMed ID: 33452398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic chalcones as potential tool for acute- and chronic-pain control.
    Rocha LW; Sonza DR; Broering MF; Nunes R; de Campos-Buzzi F; Corrêa R; Silva RL; Cunha TM; Santin JR; Quintão NLM
    Biomed Pharmacother; 2018 Aug; 104():437-450. PubMed ID: 29787991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.